TORONTO, Oct. 24, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 fiscal 2024 financial results on Thursday, November 7, 2024. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will be hosted by Mr. Craig Millian, Chief Executive Officer, and Mr. John Hanna, Chief Financial Officer. Slides to accompany management's prepared remarks will be available to view via the webcast.
Read more at newswire.caHLS Therapeutics to Host Q3 Fiscal 2024 Financial Results Conference Call
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.